{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T16:06:49Z","timestamp":1726848409289},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T00:00:00Z","timestamp":1383696000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s10157-013-0897-2","type":"journal-article","created":{"date-parts":[[2013,11,5]],"date-time":"2013-11-05T03:19:09Z","timestamp":1383621549000},"page":"269-273","source":"Crossref","is-referenced-by-count":7,"title":["Fabry disease: experience of screening dialysis patients for Fabry disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Eiji","family":"Kusano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsu","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,6]]},"reference":[{"key":"897_CR1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/jhg.2012.68","volume":"57","author":"K Doi","year":"2012","unstructured":"Doi K, Noiri E, Ishizu T, Negishi K, Suzuki Y, Hamasaki Y, et al. High-throughput screening identified disease-causing mutants and functional variants of \u03b1-galactosidase A gene in Japanese male hemodialysis patients. J Hum Genet. 2012;57:575\u20139.","journal-title":"J Hum Genet"},{"issue":"1","key":"897_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","volume":"79","author":"M Spada","year":"2006","unstructured":"Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G, Sakuraba H, et al. High incidence of later-onset fabry disease revealed by newborn screening. Am J Hum Genet. 2006;79(1):31\u201340.","journal-title":"Am J Hum Genet"},{"issue":"10","key":"897_CR3","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/humu.21074","volume":"30","author":"WL Hwu","year":"2009","unstructured":"Hwu WL, Chien YH, Lee NC, Chiang SC, Dobrovolny R, Huang AC, et al. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936\u00a0+\u00a0919G\u00a0>\u00a0A (IVS4\u00a0+\u00a0919G\u00a0>\u00a0A). Hum Mutat. 2009;30(10):1397\u2013405.","journal-title":"Hum Mutat"},{"key":"897_CR4","unstructured":"The state of chronic dialysis therapy in Japan (as of 31st December 2010). J Jpn Soc Dial Ther 2012;45:1\u201347."},{"issue":"23\u201324","key":"897_CR5","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.cca.2010.07.038","volume":"411","author":"C Auray-Blais","year":"2010","unstructured":"Auray-Blais C, Ntwari A, Clarke JT, Warnock DG, Oliveira JP, Young SP, et al. How well does urinary lyso-Gb3 function as a biomarker in Fabry disease? Clin Chim Acta. 2010;411(23\u201324):1906\u201314.","journal-title":"Clin Chim Acta"},{"issue":"3","key":"897_CR6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2010.03.020","volume":"100","author":"T Togawa","year":"2010","unstructured":"Togawa T, Kodama T, Suzuki T, Sugawara K, Tsukimura T, Ohashi T, et al. Plasma globotriaosylsphingosine as a biomarker of Fabry disease. Mol Genet Metab. 2010;100(3):257\u201361.","journal-title":"Mol Genet Metab"},{"key":"897_CR7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ymgme.2012.10.018","volume":"107","author":"M Kobayashi","year":"2012","unstructured":"Kobayashi M, Ohashi T, Fukuda T, Yanagisawa T, Inomata T, Nagaoka T, et al. No accumulation of globotriaosylceramide in the heart of a patient with the E66Q mutation in the \u03b1-galactosidase A gene. Mol Genet Metab. 2012;107:711\u20135.","journal-title":"Mol Genet Metab"},{"issue":"13","key":"897_CR8","doi-asserted-by":"crossref","first-page":"7515","DOI":"10.1073\/pnas.120177997","volume":"97","author":"T Takenaka","year":"2000","unstructured":"Takenaka T, Murray GJ, Qin G, Quirk JM, Ohshima T, Qasba P, et al. Long-term enzyme correction and lipid reduction in multiple organs of primary and secondary transplanted Fabry mice receiving transduced bone marrow cells. Proc Natl Acad Sci USA. 2000;97(13):7515\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"897_CR9","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1073\/pnas.051634498","volume":"98","author":"SC Jung","year":"2001","unstructured":"Jung SC, Han IP, Limaye A, Xu R, Gelderman MP, Zerfas P, et al. Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice. Proc Natl Acad Sci USA. 2001;98(5):2676\u201381.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"897_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, et al. International collaborative Fabry disease study group. Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry\u2019s disease. N Engl J Med. 2001;345(1):9\u201316.","journal-title":"N Engl J Med"},{"issue":"21","key":"897_CR11","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann R, Kopp JB, Austin HA 3rd, Sabnis S, Moore DF, Weibel T, et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA. 2001;285(21):2743\u20139.","journal-title":"JAMA"},{"issue":"18","key":"897_CR12","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2119\/molmed.2011.00248","volume":"10","author":"T Tsukimura","year":"2012","unstructured":"Tsukimura T, Kawashima I, Togawa T, Kodama T, Suzuki T, Watanabe T, et al. Efficient uptake of recombinant \u03b1-galactosidase A produced with a gene-manipulated yeast by Fabry mice kidneys. Mol Med. 2012;10(18):76\u201382.","journal-title":"Mol Med"},{"issue":"1","key":"897_CR13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2011.01.013","volume":"103","author":"T Tsukimura","year":"2011","unstructured":"Tsukimura T, Chiba Y, Ohno K, Saito S, Tajima Y, Sakuraba H. Molecular mechanism for stabilization of a mutant \u03b1-galactosidase A involving M51I amino acid substitution by imino sugars. Mol Genet Metab. 2011;103(1):26\u201332.","journal-title":"Mol Genet Metab"},{"key":"897_CR14","unstructured":"http:\/\/www.amicustherapeutics.com\/default.asp ."},{"issue":"5","key":"897_CR15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ajhg.2009.09.016","volume":"85","author":"Y Tajima","year":"2009","unstructured":"Tajima Y, Kawashima I, Tsukimura T, Sugawara K, Kuroda M, Suzuki T, et al. Use of a modified alpha-N-acetylgalactosaminidase in the development of enzyme replacement therapy for Fabry disease. Am J Hum Genet. 2009;85(5):569\u201380.","journal-title":"Am J Hum Genet"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0897-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-013-0897-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-013-0897-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:40:11Z","timestamp":1564620011000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-013-0897-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,6]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["897"],"URL":"https:\/\/doi.org\/10.1007\/s10157-013-0897-2","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,6]]}}}